Related Experiment Video
Updated: Jan 18, 2026
05:25
Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research
Published on: July 14, 2023
1.9K
Elucidation of Lyme arthritis
Allen C Steere1, Lisa Glickstein
1Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. asteere@partners.org
Nature Reviews. Immunology
|March 26, 2004
Summary
Lyme arthritis, caused by a tick-borne spirochete, often resolves with antibiotics. However, some patients develop persistent joint inflammation, offering insights into chronic inflammatory arthritis.
Area of Science:
- Infectious Diseases
- Rheumatology
- Immunology
Background:
- Lyme arthritis was previously misdiagnosed as juvenile or adult rheumatoid arthritis.
- It is caused by a tick-borne spirochete that triggers joint inflammation.
- While antibiotics cure most cases, 10% develop persistent synovitis.
Purpose of the Study:
- To elucidate the progression of Lyme arthritis from acute infection to chronic synovitis.
- To enhance understanding of chronic inflammatory arthritis, including rheumatoid arthritis.
Main Methods:
- Clinical observation and diagnosis of Lyme arthritis.
- Assessment of treatment responses to antibiotics.
- Monitoring of persistent synovitis post-treatment.
Main Results:
- Lyme arthritis is caused by a spirochete disseminating to joints.
- Antibiotic therapy resolves arthritis in most patients.
- Approximately 10% of US patients experience persistent synovitis despite treatment.
Conclusions:
- Understanding Lyme arthritis progression aids in comprehending chronic inflammatory arthritis.
- Further research into persistent Lyme arthritis may reveal mechanisms applicable to rheumatoid arthritis.
Related Concept Videos
01:26Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
501
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
501
01:23Rheumatic Heart Disease I: Introduction
448
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
448
01:25Endocarditis I: Introduction
398
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
398
01:30Atherosclerosis I: Introduction
933
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
933
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
475
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
475